LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. LifeScienceXchange mobilises the Precision Medicine R&D community to accelerate targeted cures for every patient with a stake in our work.

Editor's Top Picks

Market Insight

Protein-Based, Network Informed Biomarkers for Alzheimer’s Diagnosis and Treatment

Satya Saxena Director, Global Proteomics, Clinical Pharmacology & Translational Medicine, Eisai

Market Insight

Avoiding the Crunch: Balancing Predictive Biomarker Validation and Companion Diagnostics

Clare Balendran Vice President, Head of Translational Development, Novo Nordisk

Market Insight

Tailoring Cancer Treatment with AI and Immunotypes

Anguraj Sadanandam Director, Centre for Global Oncology at the Institute of Cancer Research

Market Insight

Spatial Niches And Mapping Inflammatory Landscapes

Priyank Patel Senior Scientist, Boehringer Ingelheim

Market Insight

Evaluating Genomic Stability in Cell Therapy

Kalpana Pillai Technical Development Principal Scientist, Genentech

Latest Technology Spotlights

Expanding Treatment Options with Whole Transcriptome Spatial Molecular Imaging

Exploring the Cellular Universe: Transformative Frontiers in Spatial Multiomics

Multiomic Exploration Of The tumour Microenvironment

Unravelling The Tumour Microenvironment With Whole-Slide Imaging

Latest News

See all

Bayer Expands Oncology Portfolio With $1.3B Kumquat KRAS Partnership

World’s First Wireless OLED ‘Smart Contact Lens’ Tracks Ocular Biomarkers

Celebrating the Trailblazers of Personalised Healthcare at the Precision Medicine Awards 2025

Thought Leadership

Making Precision Oncology the Standard Worldwide - An Interview with the Precision Cancer Consortium

Gabriele Allegri Vice President for Global Commercial Precision Medicine, Johnson & Johnson Innovative Medicine

John Longshore Head of Scientific Affairs for Global Oncology Diagnostics, AstraZeneca

Interview with Dr D. Marshall Porterfield on leadership in the GeneLab Open Science program at NASA

D. Marshall Porterfield Professor, Purdue University

Interview with Viola Heinzelmann Schwarz on the Swiss Tumour Profiler (TuPro) study and OV Precision trial

Viola Heinzelmann Schwarz Professor, University Hospital Basel

LifeScienceXchange

Editor's Top Picks

Protein-Based, Network Informed Biomarkers for Alzheimer’s Diagnosis and Treatment

Avoiding the Crunch: Balancing Predictive Biomarker Validation and Companion Diagnostics

Tailoring Cancer Treatment with AI and Immunotypes

Spatial Niches And Mapping Inflammatory Landscapes

Evaluating Genomic Stability in Cell Therapy

Latest Technology Spotlights

Expanding Treatment Options with Whole Transcriptome Spatial Molecular Imaging

Exploring the Cellular Universe: Transformative Frontiers in Spatial Multiomics

Multiomic Exploration Of The tumour Microenvironment

Unravelling The Tumour Microenvironment With Whole-Slide Imaging

Latest News

Bayer Expands Oncology Portfolio With $1.3B Kumquat KRAS Partnership

World’s First Wireless OLED ‘Smart Contact Lens’ Tracks Ocular Biomarkers

Celebrating the Trailblazers of Personalised Healthcare at the Precision Medicine Awards 2025

Thought Leadership

Making Precision Oncology the Standard Worldwide - An Interview with the Precision Cancer Consortium

Interview with Dr D. Marshall Porterfield on leadership in the GeneLab Open Science program at NASA

Interview with Viola Heinzelmann Schwarz on the Swiss Tumour Profiler (TuPro) study and OV Precision trial

Market Insight: Across Focus Areas

Spatial Niches And Mapping Inflammatory Landscapes

Applying the Principles of Spatial Data Analysis for Generating Pseudo Time Progression of Inflammation

AI, Spatial Data, And The Future Of Medicine

Three Tools to Tackle Spatial Data at Scale

Reading Between the Layers With A 3D Multiomics Approach to Ovarian Cancer

AI-Driven Microscopy Meets Flow Cytometry

Subclonal Epigenetic Heterogeneity In ER+ Breast Cancer

evoCancerGPT: Predicting Cancer Evolution Using LLMs

Multi-Omic Single-Cell CNV Analysis In Leukemia

Advanced Liquid Biopsy for Mutation and Methylation Detection in Cancer

Biobanking and Sample Management for Clinical Biomarkers

Advancements in Biomarkers For Neurodegenerative Disorders

Fast-Tracking Precision Medicine with the CUPISCO Trial

Monitoring Tumor Response Using Plasma-Derived Cell Free DNA

A Phase II Functional Clinical Assay for Cancer Precision Medicine

LifeScienceXchange

Editor's Top Picks

Protein-Based, Network Informed Biomarkers for Alzheimer’s Diagnosis and Treatment

Avoiding the Crunch: Balancing Predictive Biomarker Validation and Companion Diagnostics

Tailoring Cancer Treatment with AI and Immunotypes

Spatial Niches And Mapping Inflammatory Landscapes

Evaluating Genomic Stability in Cell Therapy

Latest Technology Spotlights

Expanding Treatment Options with Whole Transcriptome Spatial Molecular Imaging

Exploring the Cellular Universe: Transformative Frontiers in Spatial Multiomics

Multiomic Exploration Of The tumour Microenvironment

Unravelling The Tumour Microenvironment With Whole-Slide Imaging

Latest News

Bayer Expands Oncology Portfolio With $1.3B Kumquat KRAS Partnership

World’s First Wireless OLED ‘Smart Contact Lens’ Tracks Ocular Biomarkers

Celebrating the Trailblazers of Personalised Healthcare at the Precision Medicine Awards 2025

Thought Leadership

Making Precision Oncology the Standard Worldwide - An Interview with the Precision Cancer Consortium

Interview with Dr D. Marshall Porterfield on leadership in the GeneLab Open Science program at NASA

Interview with Viola Heinzelmann Schwarz on the Swiss Tumour Profiler (TuPro) study and OV Precision trial

Market Insight: Across Focus Areas

Spatial Niches And Mapping Inflammatory Landscapes

Applying the Principles of Spatial Data Analysis for Generating Pseudo Time Progression of Inflammation

AI, Spatial Data, And The Future Of Medicine

Three Tools to Tackle Spatial Data at Scale

Reading Between the Layers With A 3D Multiomics Approach to Ovarian Cancer

AI-Driven Microscopy Meets Flow Cytometry

Subclonal Epigenetic Heterogeneity In ER+ Breast Cancer

evoCancerGPT: Predicting Cancer Evolution Using LLMs

Multi-Omic Single-Cell CNV Analysis In Leukemia

Advanced Liquid Biopsy for Mutation and Methylation Detection in Cancer

Biobanking and Sample Management for Clinical Biomarkers

Advancements in Biomarkers For Neurodegenerative Disorders

Fast-Tracking Precision Medicine with the CUPISCO Trial

Monitoring Tumor Response Using Plasma-Derived Cell Free DNA

A Phase II Functional Clinical Assay for Cancer Precision Medicine

You're just a click away